Artificial intelligence predicts dementia before onset of symptoms


Imagine if doctors could determine, many years in advance, who is likely to develop dementia. Such prognostic capabilities would give patients and their families time to plan and manage treatment and care. Thanks to artificial intelligence research conducted at McGill, this kind of predictive power could soon be available to clinicians everywhere.

McGill researchers receive over $7M to fight brain diseases of aging


The Weston Brain Institute awards over $30 million nationally for high-risk, high-reward translational research projects to help speed up the development of treatments for neurodegenerative diseases of aging. The Institute will help fund the work of five McGill researchers.

Alzheimer’s disease: It takes two (proteins) to tango


For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer’s disease. Which one is the driving force behind dementia? The answer: both of them, according to a new study.

Deux protéines « catalysent » l’Alzheimer


Depuis des années, les neuroscientifiques se demandent comment deux protéines anormales, appelées bêta-amyloïde et tau, s’accumulent dans le cerveau, finissent par l’endommager et causer la maladie d’Alzheimer. Laquelle des deux protéines « catalyse » la démence ? Les deux, selon une étude menée par des chercheurs de l’Institut universitaire en santé mentale Douglas.